U.S. market Closed. Opens in 2 days 6 hours 12 minutes

NDRA | ENDRA Life Sciences Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/AN/AN/AN/AN/A6.17K351.62K515.58K1.41M559.36K
Cost of Revenue275.45K234.26K224.41K165.25K115.01KN/A172.78K235.88K666.23K259.14K
Gross Profit-275.45K-234.26K-224.41K-165.25K-115.01K6.17K178.84K279.70K743.83K300.21K
Operating Expenses10.25M13.16M11.50M11.50M10.84M8.74M4.80M2.07M2.31M1.83M
Selling, General & Admin5.24M6.60M6.02M5.58M4.27M4.02M2.87M1.58M1.27M953.22K
Research & Development5.00M6.55M5.48M5.92M6.57M4.72M1.93M495.38K1.04M873.17K
Other Operating ExpensesN/A-21.53K-41.55K8.84K-106.90K-777.25KN/A-1.001.00N/A
Operating Income-10.52M-13.16M-11.50M-11.50M-10.84M-9.02M-4.63M-1.79M-1.57M-1.53M
Other Expenses / Income460.49K-21.53K267.06K-223.58K-2.46M-1.06M-750.90K-983.61K-710.63K-654.70K
Before Tax Income-10.06M-13.18M-11.23M-11.73M-13.31M-9.80M-5.38M-2.78M-2.28M-2.18M
Income Tax Expenses-1.0021.53K-41.55K241.27K2.25M-777.25KN/AN/AN/AN/A
Net Income-10.06M-13.20M-11.19M-11.97M-15.55M-9.80M-5.38M-2.78M-2.28M-2.18M
Interest ExpensesN/A21.53KN/A232.43K2.36MN/AN/AN/AN/AN/A
Basic Shares Outstanding9.04M2.89M2.05M959.61K375.00K225.24K137.85K3.91M3.91M3.91M
Diluted Shares Outstanding9.04M2.89M2.05M959.61K375.00K225.24K137.85K3.91M3.91M3.91M
EBITDA-10.25M-12.92M-11.32M-11.33M-10.84M-8.38M-5.32M-2.71M-2.21M-2.14M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%-135,659.38%-1,511.70%-525.70%-156.52%-383.23%
EBIT-10.06M-13.16M-11.23M-11.49M-10.95M-10.57M-5.38M-2.78M-2.28M-2.18M
EBIT Margin0.00%0.00%0.00%0.00%0.00%-171,258.73%-1,529.19%-538.30%-161.64%-389.89%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙